Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting

Author： Torti C.   Casari S.   Palvarini L.   Quiros-Roldan E.   Moretti F.   Leone L.   Patroni A.   Castelli F.   Ripamonti D.   Tramarin A.   Carosi G.   the PEC Study Group  

Publisher： Elsevier

ISSN： 0168-8510

Source： Health Policy, Vol.65, Iss.3, 2003-09, pp. : 261-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Do Reduced Inpatient Costs Associated with Highly Active Antiretroviral Therapy (HAART) Balance the Overall Cost for HIV Treatment?

By Farnham Paul G.  

Applied Health Economics and Health Policy, Vol. 8, Iss. 2, 2010-03 ,pp. : 75-88

Adis International

Access to resources Recommend Favorite

Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection

By Scalera A.  

Disease Management & Health Outcomes, Vol. 10, Iss. 2, 2002-01 ,pp. : 85-91

Adis International

Access to resources Recommend Favorite

Impacts of HIV infection and HAART use on quality of life

By Liu Chenglong   Ostrow David   Detels Roger   Hu Zheng   Johnson Lisette   Kingsley Lawrence   Jacobson Lisa  

Quality of Life Research, Vol. 15, Iss. 6, 2006-08 ,pp. : 941-949

Springer Publishing Company

Access to resources Recommend Favorite

Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection

By Gorse G.J.   Patel G.B.   Arbuckle J.A.   Belshe R.B.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 383-397

Elsevier

Access to resources Recommend Favorite

Clinical, Immunological and Virological Evolution in Patients with CD4 T-Cell Count above 500/mm3: Is there a Benefit to Treat with Highly Active Antiretroviral Therapy (HAART)?

By Piroth Lionel   Binquet Christine   Buisson Marielle   Kohli Evelyne   Duong Michel   Grappin Michèle   Abrahamowicz Michal   Quantin Catherine   Portier Henri   Chavanet Pascal  

European Journal of Epidemiology, Vol. 19, Iss. 6, 2004-06 ,pp. : 597-604

Springer Publishing Company

Access to resources Recommend Favorite